糖化血红蛋白水平与糖尿病患者血运重建后通畅性和不良肢体事件相关
本研究回顾性分析2002年5月至2018年12月因Rutherford 3至6级缺血行下肢血运重建的糖尿病患者,比较HbA1c≤7%与>7%两组。结果显示HbA1c>7%与膝下血运重建后通畅率更低及MALE增加相关,对生存无显著影响;开放手术后保肢率受影响,而腔内手术后无差异。
要点
- HbA1c>7%组膝下血运重建后通畅率和无MALE生存率显著更低。
- HbA1c>7%组截肢患者70例 vs HbA1c≤7%组38例(P = .007)。
- CLTI患者开放术后5年保肢率HbA1c>7%组64%±6% vs HbA1c<7%组86%±5%(P = .020),腔内术后相似。
核心结论
- 围术期HbA1c>7%与糖尿病患者血运重建后通畅率更差和MALE增加相关,尤其膝下血运重建,对生存无显著影响。
- 开放血运重建后保肢率受影响,而腔内血运重建后不受影响。
研究设计与样本
- 回顾性研究,纳入2002年5月至2018年12月因Rutherford 3至6级缺血行下肢血运重建的糖尿病患者。
- 706例患者中699例有HbA1c数据(775条肢体),HbA1c≤7%组311例(357条肢体),HbA1c>7%组388例(418条肢体)。
主要发现
- HbA1c>7%组较≤7%组更年轻(69.9±10.2岁 vs 71.7±9.5岁;P = .011),胰岛素使用比例更高(70% vs 49%;P < .01),慢性肾脏病患病率更低(32% vs 41%;P = .023)。
- HbA1c>7%组更常表现为CLTI(79% vs 72%;P = .019)和接受膝下干预(49% vs 42%;P = .005),解剖复杂度(TASC C/D 75% vs 77%;P = .72)和血运重建类型(开放24% vs 18%,腔内66% vs 70%,杂交10% vs 12%;P = .236)无差异。
- HbA1c>7%组膝下血运重建后通畅率和无MALE生存率显著更低,无截肢生存率和总生存率相似。
- CLTI患者开放血运重建后5年保肢率HbA1c>7%组64%±6% vs HbA1c<7%组86%±5%(P = .020),腔内干预后相似(HbA1c>7%组79%±4% vs HbA1c<7%组77%±3%;P = .631)。
- HbA1c>7%组70例患者截肢 vs HbA1c≤7%组38例(P = .007)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Poor glycemic control in the perioperative period has been reported to be associated with early and late major adverse limb events (MALEs). However, these studies were mostly from large databases or lacked long-term outcomes. We examined the long-term effects of high hemoglobin A1c (HbA1c) level on patency, MALE, limb salvage (LS) and survival after lower extremity revascularization procedures in patients with diabetes. METHODS: Patients with diabetes who underwent revascularization for Rutherford class 3 to 6 ischemia between May 2002 and December 2018 were identified. Patients with an HbA1c of ≤7% were compared with those with an HbA1c of >7% for patency, MALE, survival, LS, and amputation-free survival. RESULTS: Of 706 patients, 699 had HbA1c data (775 limbs), with 311 (357 limbs) in the HbA1c ≤7% and 388 (418 limbs) in the HbA1c >7% groups. Patients with an HbA1c of >7% were younger (69.9 ± 10.2 years vs 71.7 ± 9.5 years; P = .011), had higher lipid levels, insulin use (70% vs 49%; P < .01), American Society of Anesthesiologists classification of 4, and had a lower prevalence of chronic kidney disease (32% v s41%; P = .023). Patients with an HbA1c of >7% were more likely to present with chronic limb-threatening ischemia (CLTI) (79% vs 72%; P = .019) and undergo infrapopliteal interventions (49% vs 42%; P = .005), with no difference in anatomical complexity (TransAtlantic Inter Society Consensus class C/D, 75% vs 77%; P = .72) or type of revascularization (24% vs 18% open, 66% vs 70% endovascular, 10% vs 12% hybrid; P = .236). Patency and freedom from MALE were significantly lower in patients with an HbA1c of >7% for infrainguinal revascularizations, whereas amputation-free survival and overall survival were similar. In patients with chronic limb-threatening ischemia, LS rates at 5 years were significantly lower in patients undergoing open revascularization (HbA1c > 7%: 64% ± 6% vs HbA1c < 7%:86% ± 5%; P = .020), whereas it was similar after endovascular interventions (HbA1c > 7%:79% ± 4% vs HbA1c < 7%:77% ± 3%; P = .631). Seventy patients with an HbA1c of >7% lost limbs vs 38 patients with an HbA1c of ≤7% (P = .007). In multivariate analysis, HbA1c was associated significantly with primary patency. HbA1c, insulin use, level of intervention, and angiotensin-converting enzyme inhibitor use were associated with MALE. CONCLUSIONS: A perioperative HbA1c of >7% is associated with poorer patency rates and increased MALE, especially at the infrainguinal level revascularization in patients with diabetes, with no significant impact on survival. LS is impacted after open, but not after endovascular revascularization.
引用
- Oh K, Repasky A, Nader ND, et al. Hemoglobin A1c levels are related to patency and adverse limb events in diabetics after revascularization. J Vasc Surg. 2024. PMID: 39303863. doi:10.1016/j.jvs.2024.09.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。